HIGHLIGHTS
- who: Glioblastoma. Ellagic acid. Irinotecan. and collaborators from the (UNIVERSITY) have published the article: Antitumor activity of irinotecan with ellagic acid in C6 glioma cells, in the Journal: (JOURNAL)
- what: The authors aimed to demonstrate the antitumor effects of the treatment of Ir with EA in C6 glioma cell line.
SUMMARY
With other chemotherapeutic agents in the malignant gliomas needs further study1,7. The epithelial-to-mesenchymal transition (EMT) provides an aggressive behavior of the tumor cells by reducing the expression or loss of epithelial markers such as adherent junction proteins . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.